Back to Search
Start Over
TGF-[beta]-neutralizing antibodies improve pulmonary alveologenesis and vasculogenesis in the injured newborn lung
- Source :
- The American Journal of Physiology. July, 2007, Vol. 293 Issue 1, pL151, 11 p.
- Publication Year :
- 2007
-
Abstract
- Pulmonary injury is associated with the disruption of alveologenesis in the developing lung and causes bronchopulmonary dysplasia (BPD) in prematurely born infants. Transforming growth factor (TGF)-[beta] is an important regulator of cellular differentiation and early lung development, and its levels are increased in newborn lung injury. Although overexpression of TGF-[beta] in the lungs of newborn animals causes pathological features that are consistent with BPD, the role of endogenous TGF-[beta] in the inhibition of the terminal stage of lung development is incompletely understood. In this investigation, the hypothesis that [O.sub.2]-induced injury of the maturing lung is associated with TGF-[beta]-mediated disruption of alveologenesis and microvascular development was tested using a murine model of BPD. Here we report that treatment of developing mouse lungs with TGF-[beta]-neutralizing antibodies attenuates the increase in pulmonary cell phospho-Smad2 nuclear localization, which is indicative of augmented TGF-[beta] signaling, associated with pulmonary injury induced by chronic inhalation of 85% oxygen. Importantly, the neutralization of the abnormal TGF-[beta] activity improves quantitative morphometric indicators of alveologenesis, extracellular matrix assembly, and microvascular development in the injured developing lung. Furthermore, exposure to anti-TGF-[beta] antibodies is associated with improved somatic growth in hyperoxic mouse pups and not with an increase in pulmonary inflammation. These studies indicate that excessive pulmonary TGF-[beta] signaling in the injured newborn lung has an important role in the disruption of the terminal stage of lung development. In addition, they suggest that anti-TGF-[beta] antibodies may be an effective therapy for preventing some important developmental diseases of the newborn lung. bronchopulmonary dysplasia; transforming growth factor-[beta] doi:10.1152/ajplung.00389.2006
Details
- Language :
- English
- ISSN :
- 00029513
- Volume :
- 293
- Issue :
- 1
- Database :
- Gale General OneFile
- Journal :
- The American Journal of Physiology
- Publication Type :
- Academic Journal
- Accession number :
- edsgcl.167107410